LEPU CFMS LEPU-8880
Introduction:
• Fast: test time about 25min • High accuracy • Easy to use • Intelligent operation
参考价:
US$8,000–20,000/unit
Overview
· Thromboelastography (TEG) analyzer for whole-blood coagulation and fibrinolysis assessment
· Electromagnetic detection technology
· 4 independent testing channels
· Test time of approximately 20–25 minutes
· Requires only 0.36 mL whole blood per test
· Independent temperature control for each channel
· More than 20 international standard parameters
· No external computer required
· Automatic testing with graphical and data-based reports
· Designed for coagulation monitoring, transfusion management and antiplatelet/anticoagulant therapy monitoring
Specifications
| Specification | CFMS LEPU-8880 |
|---|---|
| Product Type | Thromboelastography Analyzer |
| Assay Technology | Electromagnetic Method |
| Sample Type | Sodium citrate anticoagulated whole blood; heparin anticoagulated whole blood |
| Sample Volume | 0.36 mL/test |
| Test Time | 20–25 min |
| Testing Channels | 4 |
| Computer Requirement | No external computer required |
| Temperature Control | Independent temperature control for each channel |
| Export Parameters | More than 20 international standard parameters |
| Duplicate Detection | CV ≤15% |
| Report Mode | Graphical and numerical data |
| Diagnosis Support | Tentative diagnostic advice |
| Input Voltage | AC 220 V ±22 V |
| Frequency | 50 Hz ±1 Hz |
| Power Consumption | 120 W |
| Dimensions (L × W × H) | 320 × 320 × 380 mm |
| Weight | 15.4 kg |
Product Details
1. Electromagnetic Detection
CFMS LEPU-8880 uses an electromagnetic measurement method that converts mechanical motion into an electrical signal, providing continuous assessment of coagulation-related changes in whole blood.
2. Four-Channel Testing
The analyzer provides four independent testing channels, with independent temperature control for each channel. This allows multiple samples to be tested simultaneously.
3. Low Sample Volume
Only 0.36 mL of whole blood is required for each test. The system supports sodium citrate anticoagulated and heparin anticoagulated whole blood.
4. Comprehensive Coagulation Assessment
The system can provide more than 20 international standard parameters, supporting assessment of coagulation function, blood loss risk and treatment response.
5. Clinical Applications
CFMS LEPU-8880 can support prenatal thrombotic-risk assessment, coagulation disorder screening, individualized blood transfusion, cardiac surgery blood-loss management, antiplatelet and anticoagulant therapy monitoring, and detection of residual heparin.













